
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia is well-positioned to benefit from the favorable tailwinds supporting the patient engagement market, with its integrated platform addressing key challenges in healthcare delivery. The company's emphasis on aggressive pricing strategies and its competitive advantage in the space are key factors driving its success. Although the top-line deceleration and the company's "Rule of 40" objective are concerning, ongoing cost-saving efforts and recent restructuring plans should help boost profitability. With its strong financials and potential for future growth, Phreesia is a promising investment opportunity.
Bears say
Phreesia is facing several challenges that could negatively impact its stock price. These include declining subscription revenues, uncertainty regarding pending litigation, and increasing competition from smaller vendors and well-capitalized players in the healthcare industry. Additionally, the company's heavy reliance on the selling season for most of its business and potential risks such as regulatory changes and provider consolidation could also hinder its growth potential. Despite maintaining a BUY rating, analysts have only set a $14 price target for the stock, citing potential risks to the company's financial performance.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares